If methotrexate does not work for RA, what is a common next step?

Prepare for the CMS II Rheumatology E1 Exam with our comprehensive quiz. Study using flashcards and multiple-choice questions, each with hints and explanations. Get ready for success!

Multiple Choice

If methotrexate does not work for RA, what is a common next step?

Explanation:
When methotrexate isn’t providing adequate control of rheumatoid arthritis, the common next step is to escalate therapy by adding a biologic DMARD that targets a key inflammatory pathway, most often a TNF-alpha inhibitor. Blocking TNF-alpha helps reduce synovial inflammation, slow joint damage, and improve symptoms and function. Using a TNF inhibitor in combination with methotrexate enhances efficacy and lowers the chance that the body will develop antibodies against the biologic, making the treatment more effective over time. Other biologics such as rituximab or abatacept can be used in certain situations or after TNF inhibitors, and non-biologic options like leflunomide are alternatives, but the typical next step after MTX failure is adding a TNF-alpha inhibitor.

When methotrexate isn’t providing adequate control of rheumatoid arthritis, the common next step is to escalate therapy by adding a biologic DMARD that targets a key inflammatory pathway, most often a TNF-alpha inhibitor. Blocking TNF-alpha helps reduce synovial inflammation, slow joint damage, and improve symptoms and function. Using a TNF inhibitor in combination with methotrexate enhances efficacy and lowers the chance that the body will develop antibodies against the biologic, making the treatment more effective over time. Other biologics such as rituximab or abatacept can be used in certain situations or after TNF inhibitors, and non-biologic options like leflunomide are alternatives, but the typical next step after MTX failure is adding a TNF-alpha inhibitor.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy